• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates

cafead

Administrator
Staff member
  • cafead   May 07, 2024 at 11:22: AM
via Kenvue (KVUE.N), opens new tab will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter profit.
Since its spinoff from Johnson & Johnson (JNJ.N), opens new tab last year, Kenvue has focused on its 15 priority brands and in February announced it would increase its advertising spending this year.

article source